Skip to main content
. Author manuscript; available in PMC: 2011 Dec 1.
Published in final edited form as: Biol Blood Marrow Transplant. 2010 Jun 1;16(12):1674–1681. doi: 10.1016/j.bbmt.2010.05.016

Table 3.

Metabolic parameters of ALL survivors, stratified by HCT status.

Outcomes Non-HCT
n=48
HCT
n=26
P-value
Height z-score, mean (±SD) 0.30 ± 0.99 −0.59 ± 1.19 <0.01
BMI z-score, mean (±SD) 0.80 ± 0.92 0.54 ± 1.29 0.31
BMI ≥25 or ≥85th percentile for age & sex, n (%) 19 (39.6) 11 (42.3) 1.00
  BMI ≥30 or ≥95th percentile for age & sex, n (%) 13 (27.1) 6 (23.1) 0.79
Waist ≥90th percentile for age & sex1, n (%) 13 (27.1) 7 (26.9) 1.00
Waist-hip ratio, mean (±SD) 0.83 (0.07) 0.90 (0.06) <0.01
Blood pressure ≥120/80 or ≥90th percentile for age & height, n (%) 8 (16.7) 11 (42.3) 0.03
Glucose, median (range), mg/dL 82 (43–96) 82 (63–110) 0.76
Insulin, median (range), mU/L 6.5 (1.0, 26.9) 11.7 (1.0, 39.6) <0.01
  HOMA-IR, median (range) 1.32 (0.11, 5.51) 2.64 (0.18, 10.76) <0.01
Triglycerides, median (range), mg/dL 63 (16, 177) 127 (63, 327) <0.01
HDL, median (range), mg/dL 54 (33, 108) 45 (32, 63) <0.01
Cardiometabolic traits, n (%)2
  0 24 (50.0) 4 (15.4)
  1 14 (29.2) 8 (30.8) Overall
  2 8 (16.7) 8 (30.8) <0.01
  ≥3 2 (4.2) 6 (23.1)

HOMA-IR: homeostasis model assessment of insulin resistance

1

Or if waist circumference ≥80 cm (females), ≥94 cm (males).

2

As defined by the Consensus criteria (Table 1).